Akero Therapeutics appoints new Chief Technology Officer By Investing.com

Published on 1 May 2024 on Investing.com

With nearly three decades of experience in biopharmaceutical development and manufacturing, Gangloff...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we ...

Insider Monkey · via Yahoo Finance 3 Feb 2025

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we a...

Insider Monkey · via Yahoo Finance 2 Feb 2025

Yale Catriona, Chief Development Officer at Akero Therapeutics, Inc. (NASDAQ:AKRO), recently sold...

Investing.com 31 Jan 2025

The company remains on track for potential regulatory filings, subject to positive clinical resul...

Zacks · via Yahoo Finance 29 Jan 2025

We recently compiled a list of the 10 Firms Post Impressive Gains on Monday. In this article, we ...

Insider Monkey · via Yahoo Finance 28 Jan 2025

On Monday, Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results fr...

Benzinga · via Yahoo Finance 27 Jan 2025

Shares of Akero Therapeutics, Inc. (Nasdaq: NASDAQ:AKRO) soared 92% following the release of...

Investing.com 27 Jan 2025

Akero Therapeutics Inc (NASDAQ: AKRO) says its candidate treatment for a serious liver disease...

Invezz 27 Jan 2025

We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential Accord...

Insider Monkey · via Yahoo Finance 4 Dec 2024

On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdi...

GuruFocus.com · via Yahoo Finance 17 Oct 2024